Meanwhile, Huangfu and their team (40) noted that elevated levels of Fusobacterium nucleatum were not only closely associated with KRAS mutation but also correlated with chemoresistance in CRC, aligning with our own findings. Here, KRAS is linked to colorectal carcinoma.